Podcasts about maute

Nimm Kontakt mit mir auf. Ich freue mich über deine Impulse.Willkommen zurück zu einer weiteren Episode bei "Business Beyond Mind", dem Zengarten, unter den Business Podcasts. Gemeinsam tauchen wir mit Max Maute, Vize-Weltmeister im Hallenradsport und Neuromarketing-Experte, in die faszinierende Welt des Marketings ein. Max teilt seine einzigartigen Einblicke in die psychologischen Aspekte des Marketings und erklärt, wie emotionale Trigger und Werteverständnis den Kern erfolgreicher Marketingstrategien bilden.In dieser Episode erfährst Du:Wie tiefgreifendes Verständnis für Psychologie und Neuromarketing Geschäftsstrategien transformieren kann.Praktische Ansätze und Tipps, wie Du psychologische Trigger wirksam in Dein Marketing einbinden kannst.Die Bedeutung von Authentizität und Werten in der Verbindung zu Deiner Zielgruppe.Max Maute ist nicht nur ein talentierter Hallenradsportler, sondern auch ein visionärer Marketingberater, der sich auf die psychologischen Aspekte des Marketings spezialisiert hat. Durch seine einzigartige Kombination aus Spitzensport und wissenschaftlichem Marketing bietet Max wertvolle Perspektiven für jeden, der sein Geschäft authentisch und wirkungsvoll voranbringen möchte.Entdecke, wie Du die Prinzipien des Neuromarketings nutzen kannst, um Dein Business effektiv zu positionieren und eine tiefere Verbindung zu Deinen Kunden aufzubauen. Vielen Dank an Max für die tiefen Einblicke und die inspirierende Diskussion.Wenn Dir diese Episode gefallen hat und Du denkst, dass sie anderen Unternehmern auf ihrem Weg helfen könnte, folge bitte unserem Podcast und hinterlasse eine Bewertung. Dein Feedback hilft, unsere Inhalte weiter zu verbessern und mehr Zuhörern zugänglich zu machen.Du möchtest mehr über die Arbeit von Max erfahren? Vernetze dich am Besten gleich mit Max auf LinkedIn. Hier gelangst du zu seinem LinkedIn Profil:https://www.linkedin.com/in/max-maute/Ich danke dir fürs Zuhören, bis nächste Woche Dienstag pünktlich um 7 Uhr!Alles LiebeSabalaDu willst mehr über Sabala und Möglichkeiten mit ihm zusammenzuarbeiten erfahren? Besuche einfach seine Homepage, oder kontaktiere ihn über LinkedIn.Sabalas Homepage

Do you want to know what separates successful advisors from the rest? Are you ready for insights on growth coaching, technology consulting, and advisor training and development as the foundation for scaling your business? It's easier than you may think and within your reach! Check out this episode to learn more. Welcome to another episode of The Active Advisor podcast where host Bryan Moore, ETF Capital Markets Expert at Harbor Capital, is joined by Alisa Maute, CIMA®, CAIA℠ , and EVP of Advisor Growth Solutions at LPL Financial. Alisa shares her wealth of experience in the financial services industry and her advocacy for women in finance. Some highlights from the episode: -Leaning into your superpowers as an independent advisor -The broken rung for women climbing the financial ladder -6 key characteristics of high-performing advisors

Charleston Wine + Food is a multi-day wine and food festival that takes place the first full weekend each March, and I have covered it as a media person, and/or participated as talent for all of its going-on 18 years excepting one. The following interview took place live in the midst of the Culinary Village at this year's festival, and I'm sharing it now because I already have the 2024 festival on the brain. Not only is my behind the scenes planning well underway, but tickets go on sale to the public on October 19. I lovingly call it my Super Bowl, because it is, and the connections and education from it seeds much of the work I do. One of those relationships is with Alyssa Maute Smith, my conversation partner here and the festival's Executive Director. Alyssa, a native Charlestonian, stepped into the Interim role in April of 2022, having successfully served as the festival's Marketing + Communications Director for 6 years, then in 2023 was officially granted the title. There's no mistaking the energy of Charleston Wine + Food, and Alyssa's enthusiasm for the work and for this community she calls home is a good compass for its future. And I'm proud to call her my friend.

This week on Homeopathy for Mommies, we have a wonderful guest with us to talk about Homeopathy for Plants! Cornelia Maute, the co-author of Homeopathy for Plants, has come on the podcast to share some wonderful information about using homeopathy on our garden and house plants! Cornelia will also be joining us inside the Members […] The post Homeopathy for Plants with Cornelia Maute appeared first on Ultimate Homeschool Podcast Network.

Do you have an advisory board? Why would you need one? Do the people you lean on know the role they have in your career and life? Should they? In this episode, we are talking about Mutual Mentoring with Alisa and Jillian. Alisa Maute is the Executive Vice President of Growth Solutions at LPL Financial. Previously, she served as Head of Strategic Partnerships at WisdomTree. Alisa has been married for 12 years and they have two sons and dog named Muggsy. Jillian DelSignore is Head of Strategic Growth and Solutions for FLX Networks and sits on the board of Women in ETFs. She lives with her husband and son in Chicago. WE are thrilled to not only have Jillian back on the show but welcome Alisa to We Talk Careers Podcast. Kristine Delano discusses the importance of advising, but not managing in mutual mentoring relationships. Listen on your favorite podcast platform. We Talk Careers Podcast. Follow on Instagram kristine.delano.writer  Visit www.womeninetfs.com to find additional support in the ETF industry.  Go to www.kristinedelano.com for your Thrive Guide: a compilation of the most requested and insightful advice from our guests on Leadership and Advancement. Book recommendations:  Michelle Obama - The Light We Carry Julia Boorstin - When Women Lead

How do you design for a retailer brand that has thousands of products? Our guest today is Todd Maute, partner at CBX. You'll learn about the structures of the retail branding and retail packaging industries, how a design idea becomes a finished product on the shelf, their advice for designers who want to go into packaging, and more.Podcast feed: subscribe to https://feeds.simplecast.com/4MvgQ73R in your favorite podcast app, and follow us on iTunes, Stitcher, or Google Podcasts.Show NotesCBX – Todd's company, a branding agencyKroger, Walmart, Target, Trader Joe's – popular retailers in the USDieline – a resource for packaging inspirationMintel's Global New Products DatabaseReach out to Todd via emailThis episode is brought to you by Zeplin. Design tools can do almost anything, and with Zeplin they can go even further. Don't spend any of your time preparing design files for your team — just let Zeplin do it for you! No more dealing with unnecessary layers to show user journeys, explain intent, or organize screens. Get started for free at zeplin.ioInterested in sponsoring an episode? Learn more here.Leave a ReviewReviews are hugely important because they help new people discover this podcast. If you enjoyed listening to this episode, please leave a review on iTunes. Here's how.

Bang hang in nau ki paai hiam // Health talk.Kawikawi + Tang thu ngaih pen // Chin Gospel Songs.

My guest today is RJ Maute. Two huge challenges, as the internet evolves from Web 2.0 to Web 3.0, are how quickly should we introduce our children to the internet and who owns our identity? RJ has worked in technology sales for 20 years. We dive into how tech companies are profiting off of our data, and how to be the best versions of ourselves in this ever changing world.In this episode we discuss:The benefits of tradition and familySeparating your identity from your jobBeing self-aware and able to find your blindspotsHow to build rapport in salesHow to make a meaningful first impressionHow to use mutual connections to expand your networkThe role of social networks in personal and professional lifeHow big tech companies know that you are home or notIs AI dangerous or a luxury?When should kids get a cell phone?Should we actually reduce our screen time?How we as individuals can can back our data and monetize ourselvesand much more...----------Subscribe on Apple PodcastsSubscribe on SpotifyFollow on FacebookFollow on InstagramWatch Full Episodes and Clips on YouTube

Imagine working so hard to build up all of these incredible packaging designs only to have them screwed up because the brand doesn't value the spec data! Make sure you visit www.specright.com/pkg to learn about how you can protect yourself before you wreck yourself. Today's episode is with Todd Maute from CBX. He and Adam have a great conversation around packaging design, Todd's history, and some things he's excited about for the future. You can connect with Todd on LinkedIn at https://www.linkedin.com/in/todd-maute-5504556/ or CBX at https://cbx.com/ This episode is available to view on the Packaging is Awesome YouTube page as well and online at www.peopleofpackaging.com Packaging is awesome

DIE STIMME DES SPORTS heißt der Podcast der SportRegion Stuttgart. Inzwischen ist die 24. Folge online. Podcast-Host De­bo­rah Dobbratz hat dabei erstmals zwei Gäste zu Gast Dieter und Max Maute. Dieter Maute wurde in seiner aktiven Laufbahn bis 1995 fünf Mal Weltmeister im Einer-Kunstradfahren und ist seit dem 1. Januar 2003 hauptamtlicher Landestrainer in Baden-Württemberg und Honorar-Bundestrainer im Bund Deutscher Radfahrer (BDR) für Kunstradsport. Er wurde in Albstadt-Tailfingen geboren und wohnt mit seiner Frau in Albstadt-Ebingen. 1995 erhielt Dieter Maute von Bundespräsident Roman Herzog das Silberne Lorbeerblatt, die höchste Auszeichnung für einen Sportler in Deutschland. 2010 wurde er vom Landessportverband Baden-Württemberg (LSVBW) als Trainer des Jahres ausgezeichnet. Er ist der Erfinder des Maute-Sprungs, bei dem man vom Sattel auf den Lenker springt. Dieter Mautes Sohn Max (22) ist ebenfalls ein erfolgreicher Kunstradfahrer. Er studiert in Konstanz Sport- und Eventmanagement und hat sich für die Teilnahme an der Heim-WM qualifiziert. Diese findet vom 29. bis zum 31. Oktober 2021 in der Stuttgarter Porsche-Arena statt. Eine Woche zuvor wird das Weltcupfinale in Albstadt die WM-Generalprobe über die Bühne gehen. Die beiden Macher dieses Events sind Dieter und Max Maute. Sie wollen dabei am 23. Oktober 2021 neue Maßstäbe setzen: den Sport in einem spektakulären Umfeld präsentieren. Inklusive Show, Musik, Lichteffekten, speziellem Catering. Popcorn statt Bockwurst lautet die Devise.

DIE STIMME DES SPORTS heißt der Podcast der SportRegion Stuttgart. Inzwischen ist die 24. Folge online. Podcast-Host De­bo­rah Dobbratz hat dabei erstmals zwei Gäste zu Gast – Dieter und Max Maute. Dieter Maute wurde in seiner aktiven Laufbahn bis 1995 fünf Mal Weltmeister im Einer-Kunstradfahren und ist seit dem 1. Januar 2003 hauptamtlicher Landestrainer in Baden-Württemberg und Honorar-Bundestrainer im Bund Deutscher Radfahrer (BDR) für Kunstradsport. Er wurde in Albstadt-Tailfingen geboren und wohnt mit seiner Frau in Albstadt-Ebingen. 1995 erhielt Dieter Maute von Bundespräsident Roman Herzog das „Silberne Lorbeerblatt“, die höchste Auszeichnung für einen Sportler in Deutschland. 2010 wurde er vom Landessportverband Baden-Württemberg (LSVBW) als „Trainer des Jahres“ ausgezeichnet. Er ist der Erfinder des „Maute-Sprungs“, bei dem man vom Sattel auf den Lenker springt. Dieter Mautes Sohn Max (22) ist ebenfalls ein erfolgreicher Kunstradfahrer. Er studiert in Konstanz Sport- und Eventmanagement und hat sich für die Teilnahme an der Heim-WM qualifiziert. Diese findet vom 29. bis zum 31. Oktober 2021 in der Stuttgarter Porsche-Arena statt. Eine Woche zuvor wird das Weltcupfinale in Albstadt die WM-Generalprobe über die Bühne gehen. Die beiden „Macher“ dieses Events sind Dieter und Max Maute. Sie wollen dabei am 23. Oktober 2021 neue Maßstäbe setzen: den Sport in einem spektakulären Umfeld präsentieren. Inklusive Show, Musik, Lichteffekten, speziellem Catering. Popcorn statt Bockwurst lautet die Devise.

DIE STIMME DES SPORTS heißt der Podcast der SportRegion Stuttgart. Inzwischen ist die 24. Folge online. Podcast-Host De­bo­rah Dobbratz hat dabei erstmals zwei Gäste zu Gast Dieter und Max Maute. Dieter Maute wurde in seiner aktiven Laufbahn bis 1995 fünf Mal Weltmeister im Einer-Kunstradfahren und ist seit dem 1. Januar 2003 hauptamtlicher Landestrainer in Baden-Württemberg und Honorar-Bundestrainer im Bund Deutscher Radfahrer (BDR) für Kunstradsport. Er wurde in Albstadt-Tailfingen geboren und wohnt mit seiner Frau in Albstadt-Ebingen. 1995 erhielt Dieter Maute von Bundespräsident Roman Herzog das Silberne Lorbeerblatt, die höchste Auszeichnung für einen Sportler in Deutschland. 2010 wurde er vom Landessportverband Baden-Württemberg (LSVBW) als Trainer des Jahres ausgezeichnet. Er ist der Erfinder des Maute-Sprungs, bei dem man vom Sattel auf den Lenker springt. Dieter Mautes Sohn Max (22) ist ebenfalls ein erfolgreicher Kunstradfahrer. Er studiert in Konstanz Sport- und Eventmanagement und hat sich für die Teilnahme an der Heim-WM qualifiziert. Diese findet vom 29. bis zum 31. Oktober 2021 in der Stuttgarter Porsche-Arena statt. Eine Woche zuvor wird das Weltcupfinale in Albstadt die WM-Generalprobe über die Bühne gehen. Die beiden Macher dieses Events sind Dieter und Max Maute. Sie wollen dabei am 23. Oktober 2021 neue Maßstäbe setzen: den Sport in einem spektakulären Umfeld präsentieren. Inklusive Show, Musik, Lichteffekten, speziellem Catering. Popcorn statt Bockwurst lautet die Devise.

DIE STIMME DES SPORTS heißt der Podcast der SportRegion Stuttgart. Inzwischen ist die 24. Folge online. Podcast-Host De­bo­rah Dobbratz hat dabei erstmals zwei Gäste zu Gast Dieter und Max Maute. Dieter Maute wurde in seiner aktiven Laufbahn bis 1995 fünf Mal Weltmeister im Einer-Kunstradfahren und ist seit dem 1. Januar 2003 hauptamtlicher Landestrainer in Baden-Württemberg und Honorar-Bundestrainer im Bund Deutscher Radfahrer (BDR) für Kunstradsport. Er wurde in Albstadt-Tailfingen geboren und wohnt mit seiner Frau in Albstadt-Ebingen. 1995 erhielt Dieter Maute von Bundespräsident Roman Herzog das Silberne Lorbeerblatt, die höchste Auszeichnung für einen Sportler in Deutschland. 2010 wurde er vom Landessportverband Baden-Württemberg (LSVBW) als Trainer des Jahres ausgezeichnet. Er ist der Erfinder des Maute-Sprungs, bei dem man vom Sattel auf den Lenker springt. Dieter Mautes Sohn Max (22) ist ebenfalls ein erfolgreicher Kunstradfahrer. Er studiert in Konstanz Sport- und Eventmanagement und hat sich für die Teilnahme an der Heim-WM qualifiziert. Diese findet vom 29. bis zum 31. Oktober 2021 in der Stuttgarter Porsche-Arena statt. Eine Woche zuvor wird das Weltcupfinale in Albstadt die WM-Generalprobe über die Bühne gehen. Die beiden Macher dieses Events sind Dieter und Max Maute. Sie wollen dabei am 23. Oktober 2021 neue Maßstäbe setzen: den Sport in einem spektakulären Umfeld präsentieren. Inklusive Show, Musik, Lichteffekten, speziellem Catering. Popcorn statt Bockwurst lautet die Devise.

DIE STIMME DES SPORTS heißt der Podcast der SportRegion Stuttgart. Inzwischen ist die 24. Folge online. Podcast-Host De­bo­rah Dobbratz hat dabei erstmals zwei Gäste zu Gast Dieter und Max Maute. Dieter Maute wurde in seiner aktiven Laufbahn bis 1995 fünf Mal Weltmeister im Einer-Kunstradfahren und ist seit dem 1. Januar 2003 hauptamtlicher Landestrainer in Baden-Württemberg und Honorar-Bundestrainer im Bund Deutscher Radfahrer (BDR) für Kunstradsport. Er wurde in Albstadt-Tailfingen geboren und wohnt mit seiner Frau in Albstadt-Ebingen. 1995 erhielt Dieter Maute von Bundespräsident Roman Herzog das Silberne Lorbeerblatt, die höchste Auszeichnung für einen Sportler in Deutschland. 2010 wurde er vom Landessportverband Baden-Württemberg (LSVBW) als Trainer des Jahres ausgezeichnet. Er ist der Erfinder des Maute-Sprungs, bei dem man vom Sattel auf den Lenker springt. Dieter Mautes Sohn Max (22) ist ebenfalls ein erfolgreicher Kunstradfahrer. Er studiert in Konstanz Sport- und Eventmanagement und hat sich für die Teilnahme an der Heim-WM qualifiziert. Diese findet vom 29. bis zum 31. Oktober 2021 in der Stuttgarter Porsche-Arena statt. Eine Woche zuvor wird das Weltcupfinale in Albstadt die WM-Generalprobe über die Bühne gehen. Die beiden Macher dieses Events sind Dieter und Max Maute. Sie wollen dabei am 23. Oktober 2021 neue Maßstäbe setzen: den Sport in einem spektakulären Umfeld präsentieren. Inklusive Show, Musik, Lichteffekten, speziellem Catering. Popcorn statt Bockwurst lautet die Devise.

Eki Maute leitet seit über 20 Jahren Gleitschirm-Sicherheitstrainings und hat eine ganz eigene Vorstellung vom Glück des Fliegens. +++ Stell Dir einen Sicherheitstrainer vor, der selbst am liebsten ohne Helm, Protektor, Rettung und dann noch barfuß fliegen geht. Für DHV-Lehrmeinungs- und Sicherheitsapostel wirkt so ein Freigeist natürlich wie ein Dorn im Auge. Allerdings ist Eki Maute, Leiter der Flugschule Achensee, eine anerkannte Größe in der Szene. Bei aller Provokation: Sein Wort, sein Wissen und seine Erfahrung haben Gewicht. Eki geht es vor allem darum, dass das Fliegen die Menschen glücklich machen sollte. Sicherheit gehört dazu, aber auch diese Momente des vollkommenen Loslassens. „Hangloose“ nennt er seine liebste Flugfigur oder Flugübung, bei der es darum geht, einfach nur unterm Schirm abzuhängen und das Gefühl des wohligen Getragenseins im Hier-und-Jetzt zu erleben. Wer nun meint, das klinge etwas spirituell, der liegt nicht falsch. Allerdings kennt Eki auch die andere Seite: Das Schauen auf Leistungsmaßstäbe, der Vergleich mit anderen, die Lust sich zu messen und mit seinem Können zu imponieren. In dieser 59. Folge von Podz-Glidz erzählt Eki Maute von all dem. Wir sprechen darüber, wie er zum Fliegen fand und zum Sicherheitstrainer wurde; welche prägende Rolle Fluglehrer für ihre Zöglinge haben; was einen guten Piloten ausmacht; die enormen Leistungsansprüche heutiger Piloten; die spirituelle Seite des Fliegens und warum es für ihn noch immer so wichtig ist, im simplen Fliegen das pure Glück zu finden. +++ Wenn Du Podz-Glidz und den Blog Lu-Glidz fördern möchtest, so findest Du alle zugehörigen Infos unter: https://www.lu-glidz.blogspot.com/p/fordern.html +++ Musik dieser Folge: Track: Wandering Soul Artist: Asher Fulero https://www.youtube.com/watch?v=3_LCO0mQCjM

The “Lights” are powerful frequencies of Divine energy that Holy Fire® Reiki brought to our awareness. Our group introduces them to you and explains how you can access them. We also share brief meditations with the light of courage, truth, peace, beauty, compassion and joy.In March, we have Licensed Usui/Holy Fire® III Reiki level 1&2 and Usui/Holy Fire®III Reiki Masters, Holy Fire®III Karuna Reiki and (non-licensed) Animal Reiki classes in the Australian Eastern time zone. These are evening classes in North America, the evening BEFORE the dates shown. Please join us if they speak to you.International Center for Reiki Training websiteHoly Fire Reiki® Brings Gifts of Lights articlePam's InformationClasses: Information and Classes and Hidden Brook Farm full CalendarReiki from the Farm™ Website Sign up for our newsletter email: pam@hiddenbrook.caRegister to attend our free monthly online Reiki share hereSocial media:Reiki from the Farm™ InstagramReiki from the Farm™ FacebookReiki from the Farm™ Youtube channelMeditation music Licensed from: Nate Miller https://www.emanate7.com/ and https://www.youtube.com/user/Emanate7thank you to Music from Pixabay for the intro music

John Pynakker sits down with Oatman Fire Department Fire Chief Kathy Jenkins and Oatman FD Training Officer and Fire Marshall Mike Maute to chat about the Oatman Fire Department. Follow us on social media: Facebook: https://www.facebook.com/mohavevalleydailynews Twitter: https://twitter.com/MohaveNews Instagram: https://www.instagram.com/mohavedailynews/?hl=en YouTube Channel: https://www.youtube.com/c/MOHAVEVALLEYDAILYNEWS Looking for local, world or state news? go to http://www.mohavedailynews.com/ for the latest

A new Episode of the Serie "Exponential Tech Achievers" in the unique AI Chanel of Trust "Exponential Trust Times " by AI Exponential Thinker. Our Guest is Andra Maria Maute - Head of IT Strategy at AXA Switzerland. Dr. Lobna Karoui is pleased to welcome Andra Maria Maute in this new podcast episode to inspire girls and young women and invite them in the STEM jobs. Dr. Lobna Karoui is an Executive AI Strategy Growth Advisor and Exponential Digital Transformer for Fortune 500 & CAC40 with two decades experience in building AI products and services for millions of users. She is the president of AI Exponential thinker with a target to inspire and empower 1 Million young boys and girls, horizon 2025, about Trust Technologies and AI Opportunities. She is an international Speaker and interviewer recognized as an AI Expert by Forbes, Bloomberg and MIT. Follow us and subscribe AI Exponential Thinker, LinkedIn, Facebook and Instagram or via contact@aiexponentialthinker.com to interact with our Guests, meet great speakers and mentors from great companies such as Amazon, WEF, Harvard and more or via contact@aiexponentialthinker.com to interact with our Guests, meet great speakers and mentors from great companies such as Amazon, WEF, Harvard and more

Das Smartpone ist das Streitthema in Familien. Jetzt leg doch mal das Handy weg! Ein Satz, der wohl schon in vielen Familien gefallen ist. Ob beim Zubettgehen, am Frühstückstisch, unterwegs, oder auf der Spielplatzbank - unser Smartphone begleitet uns überall hin. Und wir gucken immer häufiger auf den Bildschirm. Was hat das für Folgen für unser Zusammenleben in der Familie? Wie beeinflusst der Smartphone-Konsum unsere Kinder? Wann ist viel überhaupt zu viel? Und was gibt es für Tipps um besser vom Smartphone loszukommen und die gemeinsame Zeit bewusster zu nutzen? Wir begleiten eine junge Familie im Alltag mit Smartphone, sprechen über Vorurteile, Handyspiele und bewusste Smartphone-Nutzung. All das in der neuen Folge von Familientreffen! Erzählt uns, wie ihr das in Euren Familien haltet mit der Smartphone-Nutzung. Unter familientreffen@ndr.de sind wir für euch erreichbar, auch für Anregungen, Fragen und Kritik zu unserem Podcast. Und wenn Euch der Podcast gefällt, freuen wir uns über eine Bewertung. Shownotes: Prof. Dr. Agnes von Wyl https://www.zhaw.ch/de/ueber-uns/person/vonw/ Paper: Der Blick zum Säugling - Gestört durch Smartphones? https://digitalcollection.zhaw.ch/bitstream/11475/14181/1/Obstetrica_11_2018_Maute_et_al..pdf Hier der Link zur aktuellen Studie "Smart-Start", https://www.zhaw.ch/de/psychologie/forschung/klinische-psychologie-und-gesundheitspsychologie/saeuglingsforschung/smart-start/ Studie zu Auswirkungen der Smartphone-Nutzung auf Kinder, Lara Wolfers, Uni Tübingen: https://www.sciencedirect.com/science/article/abs/pii/S0747563219303000?via%3Dihub https://www.iwm-tuebingen.de/www/de/personen/ma.html?uid=lwolfers Colette See, Expertin für Sucht und neue Medien, gibt im Podcast Ratschläge zum besseren Umgang mit dem Smartphone. Hier ihre Kontaktdaten. http://www.mediennetz-hamburg.de/index.php?aid=307

Exponential Tech Achievers - Host : Dr. Lobna Karoui, Executive AI Strategy Growth Advisor / Guest : Andra Maria Maute, Head of IT Strategy at AXA Switzerland. A new Episode of the Serie "Exponential Tech Achievers" in the unique AI Chanel of Trust by AI Exponential Thinker. Our Guest is Andra Maria Maute is Head of IT Strategy at AXA Switzerland. Dr. Lobna Karoui is pleased to welcome Andra Maria Maute in this new podcast episode. Dr. Lobna Karoui is an Executive AI Strategy Growth Advisor and Exponential Digital Transformer for Fortune 500 & CAC40 with two decades experience in building AI products and services for millions of users. She is the president of AI Exponential thinker with a target to inspire and empower 1 Million young boys and girls, horizon 2025, about Trust Technologies and AI Opportunities. She is an international Speaker and interviewer recognized as an AI Expert by Forbes, Bloomberg and MIT. Follow us and subscribe www.aiexponentialthinker.com or via contact@aiexponentialthinker.com to interact with our Guests, meet great speakers and mentors from great companies such as Amazon, WEF, Harvard and more

In this episode, Jeff and Alisa discuss: • How WisdomTree has differentiated themselves on asset management and value adds.• Remaining curious and taking on new tasks to help you expand your own career.• Client requirements and customizations.• Reaching minority advisors and finding new great talent.  Key Takeaways: • A good product is no longer enough to build solid relationships with clients.• Create a customized client experience, bespoke not boilerplate.• Think like an owner, not like an advisor. You sometimes have to give something up in order to grow your business further.• It's about relationships and people, not about the numbers.  "The people, the management, and how they are incentivized is really critical." —  Alisa Maute 

Das Beste für die KundenRentabilität der Gesundheit - dieses Thema hat sich der Unternehmer und Fitnessstudio-Betreiber Michael Maute auf die Fahnen geschrieben. Dabei möchte er seinen aktuellen und zukünftigen Kunden immer das Beste und Aktuellste bieten. Nicht nur im Hinblick auf die Geräte in seinen Studios, sondern auch, was die Betreuung betrifft. Und in seinen Einrichtungen sind keineswegs nur diejenigen, die Leistungssport betreiben oder ihr Sixpack noch weiter ausbauen möchten. Er möchte auch diejenigen erreichen, die vielleicht noch nicht so sportlich sind, die aber dennoch etwas für ihre Gesundheit tun möchten.Gesunde Mitarbeiter für ein gesundes UnternehmenHier hat Michael Maute in den vergangenen Jahren eine neue Zielgruppe und damit auch eine neue Herausforderung für sich entdeckt. Und die ist mittlerweile zu einer echten Herzensangelegenheit für den Unternehmer geworden. Er möchte Mitarbeiter in den Firmen zur Bewegung animieren. Er möchte die betriebliche Gesundheitsförderung voranbringen. Das ist aus seiner Sicht eine ehrliche Sache, von der alle Seiten am Ende profitieren. Die Mitarbeiter, die etwas für ihre Gesundheit tun. Die Unternehmer, die gesündere und damit auch effektivere Mitarbeiter haben.Auch wenn seiner Erfahrung nach viele Firmenchefs erkannt haben, dass es wichtig ist, in die Gesundheit seiner Mitarbeiter zu investieren, stößt Michael Maute bei einem Erstgespräch oft noch auf Skepsis. Das liegt vor allem daran, dass viele Chefs der Meinung sind, dass ihre Angestellten/Arbeiter das Angebot ohnehin nicht annehmen würden.Aufklärung baut Skepsis abMichael Maute hält dann immer dagegen. Mit einer Quote von 30 Prozent. Manchmal schließt er sogar Wetten ab. Bislang hat er keine davon verloren. Und er ist sich sicher, dass er sein Ziel jedes Mal erreicht. Um seine Glaubwürdigkeit zu wahren, räumt er den Kunden sogar ein Sonderkündigungsrecht ein. Gebrauch gemacht hat davon bislang keiner.Tickets für Hermann Scherer Live findest Du hier: hermannscherer.com/liveDas liegt auch an der Rundum-Betreuung, die er all denjenigen anbietet, die zu ihm ins Studio kommt. Der erste Schritt ist die Aufklärung. Die ist gerade bei Anfängern und Skeptikern nötig. Wie er es schafft, die Menschen zu überzeugen und was Sport mit einem Menschen machen kann, das erfährst Du in meinem aktuellen Podcast. See acast.com/privacy for privacy and opt-out information.

This week Liz and Alrik talk to Liz's production designer on her second feature film, Speed of Life, Marcie Maute! Marcie tells us about how she brought the two timelines into existence, working on a tiny budget and much more!

SÍGUEME: https: https://www.instagram.com/jordanthecurls/ QUE FUEEE Aquí estamos otra semana más broos, si estas leyendo esto, gracias por aguantarte mis vainas y ver mis ganas de hablar incoherencias, jajaja espero que te guste este capitulo y ¿Qué bolas los cubitos maggi? CUALQUIER SUGERENCIA EN LOS COMENTARIOS Gracias :3 Spotify: https://open.spotify.com/show/3F15w3Owkenx6mWGDkI0Wv Anchor: https://anchor.fm/jordan-peraza

ASCO: You’re listening to a podcast from Cancer.Net. This cancer information website is produced by the American Society of Clinical Oncology, known as ASCO, the world’s leading professional organization for doctors who care for people with cancer. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Cancer research discussed in this podcast is ongoing, so the data described here may change as research progresses. The 2019 ASCO Annual Meeting, held May 31 to June 4, brought together physicians, researchers, patient advocates, and other health care professionals from around the world to present and discuss the latest research in cancer treatment and patient care. In the annual Research Round Up podcast series, Cancer.Net Associate Editors share their thoughts on the most exciting scientific research to come out of this year’s ASCO Annual Meeting and what it means for patients. First, Dr. Jeffrey Meyerhardt will discuss 4 studies in gastrointestinal cancers, including 1 on colorectal cancer, 1 on gastric cancer, and two studies related to pancreatic cancer. Dr. Meyerhardt is the Douglas Gray Woodruff Chair in Colorectal Cancer Research, Clinical Director and Senior Physician at the Gastrointestinal Cancer Center at the Dana-Farber Cancer Institute, Deputy Clinical Research Officer at the Dana-Farber Cancer Institute, and Professor of Medicine at Harvard Medical School. He is also the Cancer.Net Associate Editor for gastrointestinal cancers. Dr. Meyerhardt: My name's Jeff Meyerhardt. I'm a gastrointestinal medical oncologist at the Dana-Farber Cancer Institute in Boston, Massachusetts. Today I'm going to discuss research on gastrointestinal cancers that were presented at the 2019 ASCO Annual Meeting. And let's talk about four studies: 1 in colon cancer, 1 in gastric cancer, and 2 studies related to pancreatic cancer, all of which are going to affect how patients are treated in the upcoming years. Starting with the studies on colon cancer, there were 2 additional studies looking at the duration of adjuvant therapy for colon cancer. Adjuvant therapy is the chemotherapy that's given after surgery for people who had a resection of their colon cancer that didn't have evidence of metastases. We give adjuvant therapy to try to prevent and reduce the risk of recurrent disease. The standard of care up till a few years ago was to give 6 months of adjuvant therapy. And for most patients who had stage III or lymph node positive disease, that was 6 months of a fluoropyrimidine, either 5-FU, or an oral form capecitabine with oxaliplatin. This was also given to some patients who have higher-risk stage II disease. Two years ago at ASCO, we learned that giving 3 months of therapy was sufficient, or what we'd describe as non-inferior, for some patients who have stage III colon cancer, particularly those who had what would be considered a better-risk stage II colon cancer, and actually particularly if they got a particular regimen of combining capecitabine and oxaliplatin. At this year's ASCO, there was a study looking at patients with stage II disease. Most of them had higher-risk stage II disease, something where they didn't have positive lymph nodes, but some other feature that made you a little bit more worried that there was a relatively higher-risk of recurrent disease. And the findings were essentially very similar to what we saw for stage III disease; that for some patients, 3 months of treatment was adequate, particularly if you gave capecitabine/oxaliplatin, and had less toxicity than 6 months of therapy. But if you gave 5-FU/leucovorin/oxaliplatin, a regimen called FOLFOX, 6 months of treatment was necessary. These studies add to the conclusion that first, we can't treat all colon cancers in the adjuvant setting the same, that we should think of them as risk adjustment, and we also have to make decisions regarding what type of treatment, which will help determine the duration of therapy. The next study I'm going to focus on is looking at gastric cancer and looking specifically at the role of immunotherapy. So what we've already known is that patients who have gastric cancer and esophageal cancer can benefit from immunotherapy in later-line therapy, so after an initial first-line or second-line chemotherapy is no longer helping a patient or is too toxic to continue. The study that was presented at ASCO this year, what is called the KEYNOTE-062 study, was actually looking at 3 different arms of therapy. One was giving a drug pembrolizumab, one of the immunotherapies alone. The second arm was giving chemotherapy alone. And the third arm was giving pembrolizumab with chemotherapy. In looking at what would be the best strategy for patients who are initially being treated for metastatic gastric cancer. They specifically looked at patients where we think there may be a higher chance of activity. So there are certain ways to look at the tumor and score what's the potential in immunotherapy would be helpful. And this is what's called the CPS score. Patients who had had a CPS score of at least 1, and they also broke it down for people that had even a higher score, greater than 10, in the analysis. And what they found is compared to doing standard chemotherapy, in this case, of fluoropyrimidine, 5-FU, or capecitabine with a platinum, cisplatin, giving pembrolizumab could be non-inferior in terms of overall survival for patients as initial therapy for metastatic gastric cancer; that they saw that in patients who had a CPS score greater than 1. They showed actually that it was superior to give pembrolizumab in terms of overall survival if the CPS score was greater than 10. What is a little curious in this study is that progression-free survival, which is how long it takes until you have to switch to therapy, wasn't actually better with pembrolizumab compared to chemotherapy for the people who had relatively lower CPS scores. But it was non-inferior for those who had a greater than 10. The second part of the study was looking at should we give chemotherapy and pembrolizumab at the same time, like the whole kitchen sink, at the same time of both giving chemotherapy and an immunotherapy. And that actually didn't add any benefit to chemotherapy alone. So it was not improvement in overall or progression-free survival. So what do we conclude from KEYNOTE-062? Well first is that there are some patients where giving an immunotherapy upfront by itself can be just as good as starting chemotherapy, particularly those who have a score that's a relatively higher likelihood of benefiting from immunotherapy. But we also learned that combining them together does not add extra bang for the buck as initial treatment. There should still be a therapy considered later, whether you start with pembrolizumab and then later get chemotherapy or vice versa. But doing them all at the beginning does not seem to add additional benefits. There were then 2 studies of note for pancreatic cancer. One of them was an adjuvant study, which again, adjuvant therapy is giving chemotherapy after surgery to try to reduce the risk of recurrent disease. What we know for pancreas cancer, there are several options to consider in terms of adjuvant therapy after surgery. For quite a few years now, the standard was giving a drug called gemcitabine. There was then a study looking at gemcitabine with an oral drug called capecitabine, again, the oral form of 5-FU, and that looked to be a little better than gemcitabine alone. And then several years, a study from the Canadian Cancer Treatment Group and then a Unicancer GI PRODIGE Group looked at a combination of folfirinox, a 4-drug regimen that's now very standard for some patients with metastatic pancreas cancer. In looking at that regimen as adjuvant therapy, compared to gemcitabine alone, that study showed a real significant improvement in terms of recurrence rate and disease-free survival for patients who got this 4-drug regimen compared to gemcitabine alone, and has really become a standard for patients who have a good performance status after their surgery. The current study that was presented at the 2019 ASCO Meeting was looking at a different combination, looking at gemcitabine plus another drug called nab-paclitaxel. It's a combination also used in metastatic pancreatic cancer. It was shown to be better than gemcitabine by itself in metastatic pancreatic cancer. And the hope would be another option for patients in the adjuvant setting. Unfortunately, the study fell a little short in terms of the primary endpoint as initially determined when the protocol was being developed, what was called an independent assessment of disease-free survival. So sending the scans and sending all the data to independent reviewers, and that again just fell a little short statistically. If you look at investigator-assessed disease-free survival, it actually was statistically significant, as well as overall survival. The conclusion for the study is even though it didn't quite meet the mark in terms of what was predefined, it does give suggestion that it is better than giving gemcitabine alone. And there are patients in the adjuvant setting for pancreas cancer where folfirinox is probably not as good of an option: it's a fairly toxic regimen. People who have a performance status having a little more difficulty recovering from the surgery or have more comorbidities, gemcitabine plus nab-paclitaxel probably still should be considered an option for these patients, compared to gemcitabine alone. The final study, which led to a plenary session, which is basically one of the 4 most attractive abstracts in the 2019 ASCO Annual Meeting this year, was looking at maintenance therapy for people with metastatic pancreatic cancer using what's called a PARP inhibitor olaparib. It was specifically for patients who had received a platinum-based chemotherapy and they had a germline mutation of BRCA. So BRCA mutations are commonly known to affect the risk of developing breast and ovarian cancer. There are 2: BRCA 1 and BRCA 2. Those also have association with increased risk of pancreatic cancer. And what we know is the PARP inhibitor, through what are called DNA repair mechanism, do seem to have activity in these various type of cancers, including for patients with metastatic pancreatic cancer. This was specifically looking at people who had metastatic pancreatic cancer. Could you get them off the more cytotoxic chemotherapy for a period of time to do something more of what would be considered a maintenance therapy. So having them for period time off toxic therapy and not impacting their overall outcome. It ends up about 4 to 7 percent of metastatic pancreatic cancer patients harbor a BRCA mutation. What we know about BRCA-mutated pancreatic cancers, they have an increased benefit from a platinum-based chemotherapy, cisplatin or oxaliplatin, so patients had to have had a platinum-based therapy to go on the study. They were on chemotherapy for at least 16 weeks and then they were randomized to stop their chemotherapy and receive elaborate versus placebo until there was disease-free, disease progression, or increased toxicity. And what we saw is that the progression-free survival, the time till they had to restart chemotherapy, actually was doubled with the group receiving the maintenance therapy with olaparib. So that was really an exciting finding and a really important finding where you can get people off of chemotherapy for a period of time until you have to restart chemotherapy. Now there is not a survival benefit that was noted yet on the study. It is still very early to look at overall survival. There are also patients who are able to crossover in terms they got olaparib, another part in their cancer treatment, because of the known benefit in metastatic disease. So overall survival may be a little harder to fully interpret, but I do think that this will become a standard for patients with BRCA-mutated colorectal cancers, to receive chemotherapy for some period of time, several months, and then if they're doing well, then to switch them to a maintenance therapy. So that is our summary of the GI cancer research from the 2019 ASCO Annual Meeting. Again, my name is Jeffrey Meyerhardt, and thank you for listening. ASCO: Thank you, Dr. Meyerhardt. Next, Dr. Guillermo Garcia-Manero will discuss a study on a new immunotherapy drug that offers promising results in patients with acute myeloid leukemia or myelodysplastic syndromes, as well as 2 additional studies that looked at t-cell therapies. Dr. Garcia-Manero is the Deputy Chair of Translational Research and Professor, Department of Leukemia, at The University of Texas MD Anderson Cancer Center in Houston, Texas, and the Chief of the Section of Myelodysplastic Syndromes at MD Anderson Cancer Center. He is also the Cancer.Net Associate Editor for Leukemia. Dr. Garcia-Manero: Hello. I am Guillermo Garcia-Manero. I am a professor in the Department of Leukemia at the University of Texas MD Anderson Cancer Center. I'm very happy to summarize some of the key presentations at this year's ASCO meeting in Chicago. Of course, ASCO is big on solid tumor malignancies, but there is more and more information regarding leukemia treatment for our patients, also, at the meeting. This year, there were a number of very interesting presentations. First, I want to start briefly saying that there was a very interesting educational symposium where Drs. Al-Kali, Sekeres, Craddock, and myself discussed how to use these hypomethylating agents, drugs like azacitidine or decitabine in patients with leukemia. This meeting was very well attended by multiple community physicians that attend ASCO, and it contained, I think, very useful information in terms of the use of these compounds for our patients. In terms of research presentations, there were multiple. The one that I actually felt was perhaps more interesting was a presentation by Dr. Sallman from the Moffitt Cancer Center in Tampa where he was describing the first results of a new therapy for patients with MDS and AML and potentially other hematological malignancies and cancers known as Hu5F9-G4. This agent is an antibody that targets a molecule called CD47. This was discovered by Dr. Maute and Dr. Weissman at Stanford. It is known to be a “don’t eat me” signal in a way kind of an alternative immune checkpoint inhibitor type of process. But this is interesting because it's focusing more around macrophages more than lymphocytes and it could have a broad use, again, not only in leukemia and hematological malignancies but potentially many other cancers. I think that this data is very striking because the results of Dr. Sallman indicate a very high level of activity with the combination of the hypomethylating agent azacitidine, in this case, both in MDS and AML. This was agnostic of molecular and cytogenetic alterations. It was well tolerated, although there was a little bit of anemia early on with administration of this therapy. But I think this was one of the most innovative and promising new potential therapies for our patients with leukemia. This drug has been shown to be active in lymphoma and now, we expect that the studies initially done in the UK and in Tampa are going to be expanded to other centers in North America, and they may actually provide with a very interesting innovative and very active new form of therapy for our patients. So I thought that was the most innovative presentation at the ASCO meeting. Of course, there were multiple other presentations. There was additional data on new FLT3 inhibitor known as gilteritinib. This drug recently approved for patients with AML. There was also further information on a new compound known as CX-01 for patients with acute myelogenous leukemia. Again, this is an interesting compound that seems to be a heparin analog, and the early studies are showing significant activity as well for our patients. There was also very interesting data in terms of the phase I results of the ZUMA-3 trial. This is a CAR T-cell type of approach for refractory patients with acute lymphocytic leukemia. And finally, this interesting presentation from the MD Anderson group with an off-the-shelf viral-specific T-cell therapy against patients with adenovirus disease that are immunosuppressed. It's actually very important in a way-- kind of similar therapies for patients that have viral complications, this group have shown, actually, significant activity of similar type of approaches for patients with BK virus and other conditions. So in summary, I think that the meeting was very important like it is every year. I think that we're starting to see presentations at ASCO for new agents of high relevance. I think that the community, at least in MDS and AML, it is very interested on the follow-up with the Hu5F9-G4 agent in combination with AZA for MDS and AML. And we're looking forward to be part and see the results of expanded phase II and potential phase III studies with this compound. And with that, I want to thank you for your attention. ASCO: Thank you Dr. Garcia-Manero. Learn more about these topics and other research presented at the 2019 ASCO Annual Meeting at www.cancer.net, including additional Research Round Up podcasts. And if this podcast was useful, please take a minute to subscribe, rate, and review the show on Apple Podcasts or Google Play. This Cancer.Net podcast is part of the ASCO Podcast Network, a collection of 9 programs covering a range of educational and scientific content offering insight into the world of cancer care. You can find all 9 shows, including this one, at podcast.asco.org. Cancer.Net is supported by Conquer Cancer, the ASCO Foundation, which funds breakthrough research for every type of cancer, helping patients everywhere. To help fund Cancer.Net and programs like it, donate at conquer.org/support.      

*Sad news, 4 soldiers na naman ang napatay sa pagtatanggol sa bayan laban sa Maute-ISIS. *Topics namin sa radio program sa www.radyolaverdad.com

Pavo Real, Salmancito Regente, Salchichas hepatiticas, Abusao Maquillao, Salmancito Regente, Islas Salafas, Lilian Encinta, NovaCapriles, Celula Kokito, Burrarush, Infamia Maxima, Montoro Transilvano, Macarena Harram y mucho mas VIDEOTECA REPORT --Sincera condena (minuto 54) http://www.rtve.es/alacarta/videos/telediario/telediario-15-horas-18-08-17/4171380/ --La casita de la fiscal guarimbera https://www.youtube.com/watch?v=QMR6pDEsoRI -- Salafos amenazando https://www.youtube.com/watch?v=BVryPqwWNjk --Producciones Gran Lider https://m.youtube.com/watch?v=KgSOp1LfcXo -- Ecologistas decentes. https://mundo.sputniknews.com/videoclub/201708011071202082-urss-revolucion-bolcheviques-lider-proletariado/ --Los moderados que te saca La Sexta https://www.youtube.com/watch?v=eogZiav3Ams ENLACES --Infamia máxima https://dninews.com/article/right-sector-activists-pull-down-zhukov-bust-odessa --Hepatitis saussages http://m.huffingtonpost.es/2017/08/21/las-salchichas-de-una-gran-cadena-de-supermercados-ingleses-podria-haber-infectado-la-hepatitis-a-miles-de-personas_a_23155791/?utm_hp_ref=es-html --Terrorismo Fiscal http://www.lainformacion.com/economia/anti-fraude-Montoro-dispara-ingresos-contribuyentes-multas-sanciones-Hacienda-fraude-fiscal_0_1054995660.html --Macarena Harram http://www.que.es/ultimas-noticias/curiosas/201708241226-adolescente-gordito-detenido-bailar-macarena.html --Relojuzo escacharrao http://www.lanacion.com.ar/2055337-el-big-ben-en-silencio-hasta-2021 --Discapacirrush https://actualidad.rt.com/actualidad/247811-marruecos-indignacion-intento-violacion-multiple-discapacitada --Tecnologia usurpadora http://periodistas-es.com/dron-suicida-israeli-usado-azerbaiyan-armenia-89813 --RumanOdoxos pedofis http://www.periodistadigital.com/religion/mundo/2017/08/19/la-iglesia-ortodoxa-rumana-implicada-en-dos-escandalos-sexuales-religion-iglesia-dios-jesus-papa-francisco-fe-abusos-sexuales-monje-obispo-corrupcion.shtml --La lista de Schindler http://spanish.almanar.com.lb/116642 --Rif refugees https://www.theguardian.com/world/2017/aug/23/we-would-rather-die-than-stay-there-the-refugees-crossing-from-morocco-to-spain#img-2 --Lituania si puede levantar muros. https://www.theguardian.com/world/2017/aug/24/russia-lithuania-border-fence-kaliningrad-estonia-eston-kohver --Negrissa vs Carmena http://www.20minutos.es/noticia/3118302/0/ayuntamiento-madrid-pancartas-islamofobas/ --Bundesbank repratia todo su oro https://www.bundesbank.de/Redaktion/EN/Pressemitteilungen/BBK/2017/2017_08_23_transfer_gold.html --Golpiza China-India http://www.teleamazonas.com/2017/08/ejercitos-de-china-e-india-se-enfrentan-en-la-frontera/ --Homenaje libanes http://spanish.almanar.com.lb/115564 --Rody compra cacharros http://www.hispantv.com/noticias/asia-y-oceania/351332/filipinas-comprar-armas-rusia-helicopteros-vehiculos-blindados --Libre comercio con Japon. http://www.agroinformacion.com/afectara-tlc-la-ue-japon-las-empresas-espanolas/ --Ukro cereal invasor http://www.agroinformacion.com/ucrania-ya-ha-exportado-este-ano-5-millones-de-toneladas-de-cereales-antes-de-poder-hacerlo-sin-pagar-aranceles/ --Monopolio Bayer-Monsanto investigado http://www.agroinformacion.com/la-ce-investiga-la-compra-monsanto-bayer-danara-la-competencia-glifosato-ojo-del-huracan/ --Rody se excede (por aqui le puede venir el colorismo) http://www.rtve.es/noticias/20170823/muerte-adolescente-manos-policia-paraliza-guerra-contra-drogas-duterte/1602140.shtml --Cristina la irani https://www.clarin.com/politica/audio-hector-timerman-admite-ido-siria-hablar-amia-aleppo_0_r1YMkusu-.html --Sanidad jU$A http://epmundo.com/2017/pareja-se-suicida-por-no-poder-pagar-cuentas-medicas/ --Precio de coleGAS https://businessmonkeynews.com/es/precio-amigo-polonia-quiere-un-descuento-politico-por-el-gas-de-eeuu/ --Ruina salafo-bulgara http://bnr.bg/es/post/100865856 --Perro Loco en Ukrolandia https://russian.rt.com/ussr/news/422450-poroshenko-pentagon-mattis --Fiebre Porcina en la India http://www.prensa-latina.cu/index.php?o=rn&id=110267&SEO=mas-de-mil-muertos-en-la-india-por-fiebre-porcina-en-2017 --Maldivas el ejercito en el parlamento http://prensa-latina.cu/index.php?o=rn&id=110003&SEO=continua-tension-en-el-parlamento-de-maldivas --Maldivas se asalafa peligrosamente desde 2008 https://www.turama.es/articulos/mv/31 --Pinchaitas siberianas http://www.abc.es/internacional/abci-hombre-armado-cuchillo-deja-menos-ocho-heridos-surgut-rusia-201708191111_noticia.html --Berlusconista decente https://mundo.sputniknews.com/europa/201708061071360207-italia-monumento-projorenko-siria-rusia/ --Te asalafas y te echan de menos en el barrio http://ctxt.es/es/20170816/Politica/14582/atentado-Barcelona-ripoll-ctxt-terrorismo-Cambrils-subirats.htm --El ultimo sovietico http://www.elmundo.es/f5/comparte/2017/08/03/5982c26e468aebf8518b45de.html --Imanes en paro http://bnr.bg/es/post/100861091/los-imanes-de-bulgaria-se-quedan-sin-sueldo http://bnr.bg/es/post/100865466 --Corsarios pestosos http://www.abc.es/espana/canarias/abci-barco-marruecos-suma-control-letal-buque-deriva-canarias-201708202317_noticia.html --Defendiendo Raqqah http://alwaght.com/es/news/107335 --Troleo Assange https://diario-octubre.com/2017/08/02/assange-propone-a-maduro-adoptar-la-constitucion-saudi/ --El “Puma” contra Bernie http://www.elnortedecastilla.es/gente-estilo/mensaje-puma-zapatero-20170803131609-nt.html --Lucha anti-terrorista http://www.revistavanityfair.es/realeza/articulos/suspende-regata-rey-emerito-atentado-barcelona/25653 --Depresion giratoria https://www.elconfidencial.com/espana/madrid/2017-08-24/monux-pp-diputada-fundacion-energia_1432937/ --Iman millonario https://www.srf.ch/news/schweiz/abu-ramadan-hassprediger-lebt-auf-staatskosten --Pampliego el Rescatao https://twitter.com/APampliega/status/898867792690241537 --Little Nicky deudon http://www.vozpopuli.com/espana/Pequeno-Nicolas-Manos-Limpias-Operacion-Nicolay_0_1054995734.html --El Empecinado https://es.wikipedia.org/wiki/Juan_Mart%C3%ADn_D%C3%ADez --CSI Alcanar https://www.elconfidencial.com/espana/2017-08-24/atentados-barcelona-cambrils-alcanar-mossos-jueza_1432844/?utm_source=twitter&utm_medium=social&utm_campaign=BotoneraWeb --EuroErtzaintza http://www.publico.es/politica/lucha-antiterrorista-zoido-metio-ertzaintza-europol-apoyo-pnv-presupuestos-rajoy.html --Iman Camello http://www.elmundo.es/espana/2017/08/24/599de2a4e5fdea93138b457a.html --Tigre condecorado https://diario-octubre.com/2017/08/19/rusia-premia-a-general-sirio-por-su-heroismo-ante-daesh/ --NovaCapriles http://www.elmundo.es/economia/2013/12/18/52b1d34922601dfc6c8b4585.html --Gran Lider se mea en las sanciones. https://diario-octubre.com/2017/08/20/pyongyang-neutraliza-sanciones-exporta-carbon-a-sudeste-asiatico/ -- Neolibegalismo Indio https://es.news-front.info/2017/08/09/lider-comunista-indio-denuncia-consecuencias-del-neoliberalismo/ --Susto al suomi http://www.antena3.com/noticias/mundo/finlandia-investiga-violacion-espacio-aereo-dos-cazas-espanoles_201708035982ec830cf24fa989121b91.html --Preparao te visita http://www.ecorepublicano.es/2017/08/heridos-en-los-atentados-rechazan-los.html?m=1 --Colonos quema-pupitres https://diario-octubre.com/2017/08/24/israel-destruye-las-aulas-moviles-donadas-por-europa-en-dos-pueblos-palestinos/ --Budistas vs Rohingya http://www.hispantv.com/noticias/asia-y-oceania/351299/musulmanes-rohingya-rajine-budistas-myanmar --Ruptura Paki-Saud http://timesofindia.indiatimes.com/world/pakistan/is-pakistan-losing-friends-in-gulf-due-to-terror-taint/articleshow/60200189.cms --Rohingyafugees http://timesofindia.indiatimes.com/world/south-asia/thousands-of-rohingya-flee-myanmar-for-bangladesh/articleshow/60193006.cms --Brasil en venta http://www.telesurtv.net/news/Gobierno-de-Temer-privatizara-57-empresas-estatales-de-Brasil-20170823-0050.html --Abu Al Ba Rico http://ctxt.es/es/20170816/Firmas/14575/atentado-Barcelona-yihadismo-alba-rico-ctxt.htm --Burrarush http://www.que.es/ultimas-noticias/curiosas/201708101828-jovenes-marroquies-contraen-rabia-tras.html --Propaganda Saudi en la ONU http://www.arabnews.com/node/1149761/saudi-arabia --Maute tabarra https://riafan.ru/932936-ig-na-filippinakh-gromit-cerkvi-i-ugrozhaet-pape-francisku-vorvatsya-v-rim --Monstruito en camino https://elpais.com/elpais/2017/08/01/gente/1501609595_576823.html --Vacaciones Lukhashenko http://esp.belta.by/president/view/lukashenko-exige-mantener-los-ritmos-de-la-campaa-de-recoleccin-35493-2017/ https://es.news-front.info/2017/08/22/lukachenko-ha-encargado-crear-una-supercosechadora-en-bielorrusia/ http://esp.belta.by/president/view/el-presidente-durante-la-recoleccin-35364-2017/ --Faisan Takbir http://www.publico.es/politica/terrorismo-catalunya-policias-nacionales-alertaron-yihadistas-2015-mossos-investigaban.html --Maduro narco http://www.elnuevoherald.com/noticias/mundo/america-latina/colombia-es/article168756262.html --Embajadas Damasco http://www.eluniversal.com/noticias/internacional/damasco-impone-romper-con-rebeldes-paises-que-reabran-embajadas_666506 --Guardia de Honor Ukra https://es.news-front.info/2017/08/07/medios-de-comunicacion-ucranianos-poroshenko-quebro-la-vida-del-soldado-que-se-desmayo-ante-el/ --Caza-salafos bulgaro http://bnr.bg/es/post/100859575/absuelto-petar-nizamov-conocido-como-cazador-de-inmigrantes --Uvas reptil https://mundo.sputniknews.com/increible/201708221071761437-uvas-golosinas-sabores-reino-unido/ --Refuerzos de Mohammed http://www.abc.es/internacional/abci-mohamed-indulta-quince-condenados-terrorismo-201708210920_noticia.html --Iman captador https://okdiario.com/investigacion/2017/08/19/celula-del-iman-ripoll-enviaba-terroristas-suicidas-siria-afganistan-irak-1253129 --Rusia nos venga http://www.hispantv.com/noticias/siria/351200/estado-islamico-batalla-deir-ezzor-ataque-rusia http://www.hispantv.com/noticias/siria/350844/ataca-terroristas-aviones-rusia-drones --Ukro Racoon City https://es.news-front.info/2017/08/23/cyberberkut-ucrania-prueba-biologica-de-los-ee-uu/ --Ukros afarmafiados https://es.news-front.info/2017/08/23/observador-internacional-eeuu-transformara-ucrania-en-un-desierto-con-calaveras/ --Orgasmo magufo https://www.vanitatis.elconfidencial.com/estilo/2016-08-23/cuanto-dinero-le-cuesta-a-gwyneth-paltrow-tener-un-orgasmo_1218875/ --Cyborgilipollas https://www.elconfidencial.com/tecnologia/2017-08-13/ciborg-barometro-oreja-catalan-neil_1426521/ --Chef Dabiz http://www.elcorreo.com/gente-estilo/dabiz-munoz-primer-20170813132905-nt.html --AlbioPedofis http://www.20minutos.es/noticia/3103719/0/munecas-sexual-infantil-pedofilos-reino-unido/?utm_source=Twitter-20minutos&utm_medium=Social&utm_campaign=Postlink --Dendrofilos https://elpais.com/elpais/2017/07/28/tentaciones/1501241517_091990.html?id_externo_rsoc=FB_CM --Zapatillismo judicial http://www.publico.es/economia/supremo-dice-descanso-bocadillo-no-derecho-muestra-tolerancia-empresario.html --ExPresidente magufo http://www.noticiacristiana.com/iglesia/escatologia/2017/08/ex-presidente-nigeria-cristo-fin-mundo.html --Cancer en el grifo http://www.abc.es/sociedad/abci-hallan-restos-sustancia-cancerigena-agua-grifo-holanda-201708151812_noticia.html --Congorrush masculino http://www.bbc.com/mundo/noticias-internacional-40812032?ocid=socialflow_twitter --Muerte apalillada https://www.youtube.com/watch?v=sCghKCWZZyE&feature=youtu.be --NASA; Men in Black http://www.abc.es/ciencia/abci-nasa-convoca-puesto-oficial-proteccion-planetaria-201708130220_noticia.html --Amago SKYNET http://www.teletica.com/Noticias/168896-EEUU-Cientificos-obligados-a-desconectar-2-robots-que-empezaron-a-desarrollar-entre-ellos-su-propio-lenguaje.note.aspx --Asalafe balcanico https://es.news-front.info/2017/08/23/construccion-de-mezquitas-como-parte-del-plan-saudi-para-islamizar-los-balcanes/ --Modernización adoctrinadora de peregrinos http://www.arabnews.com/node/1149781/saudi-arabia --Salmancito Gobernando http://www.arabnews.com/node/1149766/saudi-arabia --Huevos envenenados http://www.20minutos.es/noticia/3118306/0/holanda-afirma-otra-sustancia-toxica-ademas-fipronil/ --Cafeteria spreading http://www.lasprovincias.es/sociedad/mundo-viral/polemica-cafeteria-cobra-20170824140855-nt.html --Donante holandes http://www.lasprovincias.es/sociedad/padre-biologico-hijos-20170824100828-ntrc.html#ns_campaign=mod-lo-mas&ns_mchannel=ver-top-50&ns_source=estandar&ns_linkname=estandar&ns_fee=2 --NEP laboral http://www.portalparados.es/actualidad/una-cuarta-parte-de-los-contratos-firmados-en-julio-duraron-menos-de-una-semana/ --Advertencias Libias https://gaceta.es/europa/libia-frena-inmigracion-terrorismo-20170823-1016/ --Otro taxista caritativo http://www.lavanguardia.com/politica/20170823/43755545850/taxista-fia-lleva-ripoll-detenido-dejado-libre-audiencia.html --Actividad Black Kalifa http://www.20minutos.es/noticia/3117137/0/ninos-bombas-humanas/ http://www.hispantv.com/noticias/nigeria/351273/boko-haram-deguella-hombres-kijimatari --Macri anti obrero https://www.clarin.com/politica/marcha-gobierno-pone-interlocutores-duros-gremios_0_r1lTuQ5suZ.html --Bilbao-Saud connection https://actualidad.rt.com/actualidad/247983-contenedores-explosivos-salen-puerto-arabia-saudita --Jackson Hole https://es.investing.com/news/economy-news/jackson-hole-y-el-principio-del-fin-de-los-estímulos-507874 --La boda de Garzon (309 pavos el cubierto) http://www.laopiniondezamora.es/opinion/2017/08/24/boda-capitalista/1027481.html --Independes Salafos http://www.lainformacion.com/disturbios-conflictos-y-guerra/terrorismo/peligrosos-islamistas-convertidos-CUP-ERC_0_922109057.amp.html --Detenido por dejar conducir a la parienta http://www.20minutos.es/noticia/3118295/0/detiene-ciudadano-mujer-conducir-coche-arabia-saudi/

1-La popolarità dei gruppi dell'estremismo islamico va oltre la religione...Il caso di Mindanao, nelle Filippine. A Esteri una testimonianza da Marawi, dove da un mese un'organizzazione che dice di rifarsi all'ISIS tiene in ostaggio 200mila persone (Mabel Carumba, Mindanao People Peace Movement).2-“Potremmo aver ucciso al-Baghdadi, il leader dello Stato Islamico”. Lo dice il governo russo. Ma non c'è alcuna certezza (Farid Adly).3-Da Tehran a Beirut. Gli sviluppi delle guerre in Siria e in Iraq hanno già un vincitore, l'Iran. Gli Ayatollah hanno quasi un corridoio terrestre fino al Mediterraneo.4-Tanto rumore per nulla. Trump annuncia nuove misure contro Cuba, come promesso in campagna elettorale. Ma nella realtà cambierà ben poco (Alfredo Somoza).5-La violenza sulle donne in Egitto, un problema endemico. La storia del centro donne della ong COSPE alla periferia del Cairo (Gianni Toma, responsabile Medio Oriente COSPE).6-In crisi i rapporti tra Cina e Australia. Nonostante un ricco interscambio commerciale tra i due paesi ci sono molte questioni irrisolte. Lo ha confermato anche il governo di Canberra (Gabriele Battaglia)

1-La popolarità dei gruppi dell'estremismo islamico va oltre la religione...Il caso di Mindanao, nelle Filippine. A Esteri una testimonianza da Marawi, dove da un mese un'organizzazione che dice di rifarsi all'ISIS tiene in ostaggio 200mila persone (Mabel Carumba, Mindanao People Peace Movement).2-“Potremmo aver ucciso al-Baghdadi, il leader dello Stato Islamico”. Lo dice il governo russo. Ma non c'è alcuna certezza (Farid Adly).3-Da Tehran a Beirut. Gli sviluppi delle guerre in Siria e in Iraq hanno già un vincitore, l'Iran. Gli Ayatollah hanno quasi un corridoio terrestre fino al Mediterraneo.4-Tanto rumore per nulla. Trump annuncia nuove misure contro Cuba, come promesso in campagna elettorale. Ma nella realtà cambierà ben poco (Alfredo Somoza).5-La violenza sulle donne in Egitto, un problema endemico. La storia del centro donne della ong COSPE alla periferia del Cairo (Gianni Toma, responsabile Medio Oriente COSPE).6-In crisi i rapporti tra Cina e Australia. Nonostante un ricco interscambio commerciale tra i due paesi ci sono molte questioni irrisolte. Lo ha confermato anche il governo di Canberra (Gabriele Battaglia)

1-L'ISIS in estremo oriente. Nel sud delle Filippine un gruppo integralista sta mettendo a ferro e fuoco una città di 200mila abitanti. Gli scontri con l'esercito vanno avanti da una settimana (Gabriele Battaglia).2-Il Kashmir e la tentazione della guerra santa. Le nuove generazioni sempre meno attratte dalla lotta per l'indipendenza dall'India. Al suo posto si fa largo l'integralismo islamico (Camillo Pasquarelli).3-Costretta a sposarsi a 11 anni, con l'uomo che l'ha violentata. È successo in Florida, negli Stati Uniti. In America non è un caso isolato (Adele Alberti).4-È morto Manuel Noriega, l'ex-presidente di Panama. L'uomo di Washington in America Latina era finito in disgrazia dopo quasi dieci anni di dittatura militare (Alfredo Somoza).5-Angela Merkel e l'ultima chance per salvare l'Europea. Il distacco dagli Stati Uniti è un'occasione da non perdere (Alessandro Principe).6-Land grabbing: i Pigmei Baka del Camerun, cacciati dalle foreste dai grandi produttori di legno (Marta Gatti)

1-L'ISIS in estremo oriente. Nel sud delle Filippine un gruppo integralista sta mettendo a ferro e fuoco una città di 200mila abitanti. Gli scontri con l'esercito vanno avanti da una settimana (Gabriele Battaglia).2-Il Kashmir e la tentazione della guerra santa. Le nuove generazioni sempre meno attratte dalla lotta per l'indipendenza dall'India. Al suo posto si fa largo l'integralismo islamico (Camillo Pasquarelli).3-Costretta a sposarsi a 11 anni, con l'uomo che l'ha violentata. È successo in Florida, negli Stati Uniti. In America non è un caso isolato (Adele Alberti).4-È morto Manuel Noriega, l'ex-presidente di Panama. L'uomo di Washington in America Latina era finito in disgrazia dopo quasi dieci anni di dittatura militare (Alfredo Somoza).5-Angela Merkel e l'ultima chance per salvare l'Europea. Il distacco dagli Stati Uniti è un'occasione da non perdere (Alessandro Principe).6-Land grabbing: i Pigmei Baka del Camerun, cacciati dalle foreste dai grandi produttori di legno (Marta Gatti)

Episode #12 -- Maute on the Ballad of Willie and Lucille